Skip to main content
Premium Trial:

Request an Annual Quote

New York State Licenses PreventionGenetics

NEW YORK (GenomeWeb) – PreventionGenetics said late Monday that it received a New York State Department of Health license.

The company previously received CLIA accreditation, as well as ISO 15189:2012 accreditation, allowing it to perform clinical genetic testing on human specimens in the US and internationally. New York and a few other states require additional licensure, however. PreventionGenetics will now be able to perform testing on specimens from New York without an additional permit application process, the company's Founder and President James Weber said in a statement.

The Marshfield, Wisconsin-based firm said that it also is licensed for genetic testing in California, Maryland, Florida, Pennsylvania, and Rhode Island. PreventionGenetics offers sequencing and deletion/duplication tests for nearly all clinically relevant genes, including the whole-exome sequencing test PGxome, as well as DNA Banking, the long-term storage of a person's DNA. 

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.